• VIGAMOX®


Solution fights


against bacterial conjunctivitis caused by certain bacteria2


. • VIGAMOX® Solution is


the #1 prescribed branded antibiotic eyedrop for bacterial conjunctivitis in the U.S.3


.


What are other possible side effects of VIGAMOX®


Solution?


• Severe allergic reactions have been reported with other uses of moxifloxacin, the active ingredient of VIGAMOX®


immediately discontinue use and contact a doctor.


• Do not use VIGAMOX® Solution for


longer than instructed by your doctor. Prolonged use may result in overgrowth of some organisms that are not susceptible to VIGAMOX®


Solution.


• These are not all of the possible side effects of VIGAMOX®


Solution. For


more information about side effects, see the full Prescribing Information and speak with your healthcare provider or pharmacist.


What other information should I know while using VIGAMOX® • VIGAMOX®


Solution? Solution is for topical eye


use only and should not be injected or swallowed.


Reference: 1. Centers for Disease Control and Prevention. Conjunctivitis (Pink Eye): Prevention. MMWR. http://www.cdc.gov/conjunctivitis/ about/prevention.html. Accessed July 30, 2015. 2. VIGAMOX®


Solution Package Insert. 3. IMS


Health, National Prescription Audit, USC 61110 OPHTH BROAD/MED SPEC, as of July 2015.


• Do not wear contact lenses if you are experiencing eye redness or other signs or symptoms of bacterial conjunctivitis.


Solution. If a rash or allergic reaction to VIGAMOX® Solution occurs,


• To prevent contamination of the dropper tip and solution, avoid touching the dropper tip to any surface.


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.


For additional information about VIGAMOX®


Solution, please refer to


the Brief Summary of full prescribing information on the following page.


VIGAMOX®


Solution | We’re With You


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100